Genesis Healthcare Inc. Stock
Price
Target price
€0.38
€0.38
-
-
-
€33.18
03.07.21 / Tradegate
WKN: A14NEW / Symbol: GEN / Name: Genesis / Stock / Healthcare Providers & Services / Small Cap /
We currently do not receive price updates for this security
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Financial data and news for Genesis
sharewise wants to provide you with the best news and tools for Genesis, so we directly link to the best financial data sources.
Financials
News
Rithm Property Trust Q2 Earnings Call Highlights
Key Points
- Interested in Rithm Property Trust Inc.? Here are five stocks we like better.
- Rithm Property Trust reported essentially flat second-quarter earnings, with book value per share
Rithm Capital Q2 Earnings Call Highlights
Key Points
- Interested in Rithm Capital Corp.? Here are five stocks we like better.
- Rithm Capital reported strong second-quarter distributable earnings of $338.9 million, or $0.60 per diluted
Healthcare Services Group Q2 Earnings Call Highlights
Key Points
- Interested in Healthcare Services Group, Inc.? Here are five stocks we like better.
- Healthcare Services Group reported Q2 2026 revenue of $470.8 million and net income of $22.7
Cellebrite DI Eyes AI, Cloud and FedRAMP as Digital Investigations Demand Grows
Cellebrite DI (NASDAQ:CLBT) executives said the company is seeing broader customer adoption of its digital investigations platform, with artificial intelligence, cloud migration and U.S. federal
Cellebrite DI Sees Federal Rebound as AI, Defense Tools Fuel New Growth
Key Points
- Interested in Cellebrite DI Ltd.? Here are five stocks we like better.
- Federal demand is rebounding after weakness in 2025, when Cellebrite’s U.S. federal business was essentially
Cellebrite DI Q1 Earnings Call Highlights
Cellebrite DI (NASDAQ:CLBT) reported first-quarter 2026 results that management said met or exceeded the high end of its guidance for annual recurring revenue and adjusted EBITDA, while executives
Genesis Energy Q1 Earnings Call Highlights
Genesis Energy (NYSE:GEL) said first-quarter 2026 results came in “a touch below” its internal expectations, primarily due to anticipated offshore producer turnarounds, lower-than-expected